# Israeli Biologic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study

> **NCT00517998** · PHASE1 · COMPLETED · sponsor: **Aeris Therapeutics** · enrollment: 16 (actual)

## Conditions studied

- Pulmonary Emphysema
- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Biologic Lung Volume Reduction (BLVR) - 10 mL Hydrogel

## Key facts

- **NCT ID:** NCT00517998
- **Lead sponsor:** Aeris Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2010-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00517998

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00517998, "Israeli Biologic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00517998. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*